Review
Open access
2026
The Use of microRNAs for the Treatment of Atherosclerosis: Current Status
: Atherosclerosis remains the principal substrate of ischaemic heart disease and stroke, and residual cardiovascular risk persists despite intensive lipid-lowering and anti-inflammatory therapy. microRNAs (miRNAs) act as integrative regulators of endothelial activation, macrophage polarisation, foam cell formation, smo...
A. Blagov, A. Vatlin, D. Borodko et al.
· Biocell (Mendoza) · 0 citations